| Bioactivity | JNJ-40929837 succinate is a selective and orally active LTA4H (leukotriene A4 hydrolase) inhibitor. JNJ-40929837 succinate effectively inhibits aminopeptidase activity and causes serum accumulation of Pro-Gly-Pro. JNJ-40929837 succinate can be used in asthma research[1]. |
| Target | LTA4H. |
| Name | JNJ-40929837 succinate |
| CAS | 1191044-47-9 |
| Formula | C22H24N4O2S.xC4H6O4 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Low CM, et al. The development of novel LTA4H modulators to selectively target LTB4 generation. Sci Rep. 2017 Mar 17;7:44449. |
JNJ-40929837 succinate
CAS: 1191044-47-9 F: C22H24N4O2S.xC4H6O4 W:
JNJ-40929837 succinate is a selective and orally active LTA4H (leukotriene A4 hydrolase) inhibitor. JNJ-40929837 succina
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.